All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin
Crossref DOI link: https://doi.org/10.1007/s40256-017-0244-1
Published Online: 2017-08-09
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gilligan, Adrienne M.
Gandhi, Pranav
Song, Xue
Wang, Cheng
Henriques, Caroline
Sander, Stephen
Smith, David M.
License valid from 2017-08-09